EDGAR Filing Documents for 0001193125-12-067446

Form 8-K - Current report:

SEC Accession No. 0001193125-12-067446

Filing Date

2012-02-17

Accepted

2012-02-17 16:13:36

Documents

Period of Report

2012-02-13

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d303964d8k.htm	8-K	46560
2	THIRD AMENDED AND RESTATED CREDIT AND GUARANTY AGREEMENT	d303964dex101.htm	EX-10.1	1331353
3	AMENDMENT NO. 1 TO SECOND AMENDED AND RESTATED CREDIT AND GUARANTY AGREEMENT	d303964dex102.htm	EX-10.2	155507
4	SECOND SUPPLEMENTAL INDENTURE	d303964dex103.htm	EX-10.3	34248
5	SECOND SUPPLEMENTAL INDENTURE	d303964dex104.htm	EX-10.4	34213
6	THIRD SUPPLEMENTAL INDENTURE	d303964dex105.htm	EX-10.5	34226
7	FOURTH SUPPLEMENTAL INDENTURE	d303964dex106.htm	EX-10.6	34285
	Complete submission text file	0001193125-12-067446.txt		1671874

Mailing Address 7150 MISSISSAUGA ROAD MISSISSAUGA ONTARIO A6 00000

Business Address 7150 MISSISSAUGA ROAD MISSISSAUGA ONTARIO A6 00000 905 286-3000

Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)